S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
AI Stock Caught Trading Under Secret Name (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
AI Stock Caught Trading Under Secret Name (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
AI Stock Caught Trading Under Secret Name (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
AI Stock Caught Trading Under Secret Name (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
AI Stock Caught Trading Under Secret Name (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
AI Stock Caught Trading Under Secret Name (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
AI Stock Caught Trading Under Secret Name (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
AI Stock Caught Trading Under Secret Name (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
AI Stock Caught Trading Under Secret Name (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
AI Stock Caught Trading Under Secret Name (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
AI Stock Caught Trading Under Secret Name (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
AI Stock Caught Trading Under Secret Name (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024

Integer (ITGR) Competitors

$102.00
+1.82 (+1.82%)
(As of 02/23/2024 ET)

ITGR vs. MASI, TMDX, LIVN, CNMD, INMD, SLNO, IRTC, AXNX, IMCR, and NEOG

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Masimo (MASI), TransMedics Group (TMDX), LivaNova (LIVN), CONMED (CNMD), InMode (INMD), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), Axonics (AXNX), Immunocore (IMCR), and Neogen (NEOG). These companies are all part of the "medical" sector.

Integer vs.

Masimo (NASDAQ:MASI) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations, valuation and community ranking.

86.0% of Masimo shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 9.7% of Masimo shares are held by company insiders. Comparatively, 1.8% of Integer shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Masimo has higher revenue and earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Masimo$2.04B3.43$143.50M$1.6480.62
Integer$1.60B2.13$90.65M$2.6937.92

Masimo presently has a consensus target price of $121.86, indicating a potential downside of 7.83%. Integer has a consensus target price of $99.20, indicating a potential downside of 2.75%. Given Masimo's stronger consensus rating and higher possible upside, analysts plainly believe Integer is more favorable than Masimo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Masimo
0 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.14
Integer
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40

Masimo received 80 more outperform votes than Integer when rated by MarketBeat users. Likewise, 64.33% of users gave Masimo an outperform vote while only 63.08% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
MasimoOutperform Votes
449
64.33%
Underperform Votes
249
35.67%
IntegerOutperform Votes
369
63.08%
Underperform Votes
216
36.92%

Integer has a net margin of 5.68% compared to Integer's net margin of 4.19%. Integer's return on equity of 14.18% beat Masimo's return on equity.

Company Net Margins Return on Equity Return on Assets
Masimo4.19% 14.18% 6.04%
Integer 5.68%10.80%5.48%

Masimo has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Integer has a beta of 1.09, suggesting that its share price is 9% more volatile than the S&P 500.

In the previous week, Masimo had 10 more articles in the media than Integer. MarketBeat recorded 18 mentions for Masimo and 8 mentions for Integer. Integer's average media sentiment score of 0.72 beat Masimo's score of 0.38 indicating that Masimo is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Masimo
8 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Masimo beats Integer on 11 of the 18 factors compared between the two stocks.


Get Integer News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$3.41B$3.32B$5.07B$17.43B
Dividend YieldN/A1.66%2.86%3.57%
P/E Ratio37.9212.95226.0123.35
Price / Sales2.1372.273,014.227.10
Price / Cash12.4214.2190.2118.03
Price / Book2.244.074.365.93
Net Income$90.65M$88.57M$112.62M$870.05M
7 Day Performance2.63%2.10%0.93%-0.34%
1 Month Performance0.64%4.17%7.29%2.49%
1 Year Performance37.61%52.40%10.65%89.29%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MASI
Masimo
2.6741 of 5 stars
$135.14
-0.9%
$121.86
-9.8%
-20.6%$7.14B$2.04B82.406,000Upcoming Earnings
TMDX
TransMedics Group
0.2586 of 5 stars
$85.51
-2.8%
$83.33
-2.5%
+6.9%$2.79B$93.46M-77.74212Upcoming Earnings
LIVN
LivaNova
0.9186 of 5 stars
$48.90
-3.6%
$58.60
+19.8%
+15.8%$2.63B$1.02B978.202,900Earnings Report
Analyst Upgrade
News Coverage
CNMD
CONMED
4.8191 of 5 stars
$84.51
-3.6%
$120.43
+42.5%
-16.0%$2.60B$1.24B41.434,100Gap Down
INMD
InMode
2.6749 of 5 stars
$23.67
-10.6%
$36.83
+55.6%
-40.6%$1.96B$454.27M11.27480News Coverage
High Trading Volume
SLNO
Soleno Therapeutics
3.7187 of 5 stars
$45.84
-4.5%
$55.60
+21.3%
+2,492.6%$1.40BN/A-14.2425News Coverage
IRTC
iRhythm Technologies
3.1204 of 5 stars
$112.87
-5.3%
$133.13
+17.9%
-2.4%$3.46B$410.92M-32.621,793Analyst Report
News Coverage
Gap Down
AXNX
Axonics
3.4679 of 5 stars
$67.85
flat
$71.09
+4.8%
+17.6%$3.44B$273.70M-271.40610News Coverage
Positive News
IMCR
Immunocore
0.2768 of 5 stars
$71.99
-3.4%
$74.17
+3.0%
+21.4%$3.52B$173.59M-51.79408Upcoming Earnings
NEOG
Neogen
3.3299 of 5 stars
$16.44
-6.4%
$23.50
+42.9%
-10.9%$3.56B$822.45M274.052,640Positive News

Related Companies and Tools

This page (NYSE:ITGR) was last updated on 2/24/2024 by MarketBeat.com Staff